Antipyrine metabolite formation and excretion in patients with chronic renal failure
β Scribed by M. W. E. Teunissen; D. Kampf; I. Roots; N. P. E. Vermeulen; D. D. Breimer
- Publisher
- Springer
- Year
- 1985
- Tongue
- English
- Weight
- 701 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Using an electroimmunoassay technique for uromucoid in urine, the excretion of this protein has been studied in normal subjects, calcium stone formers and in patients with chronic renal failure. In the normal subjects there was no significant difference in daily excretion between males and females,
The pharmacokinetics of oral diltiazem were studied in 10 patients with chronic renal failure not requiring dialysis and in five healthy volunteers after a single dose of 120mg. We found that patients with chronic renal failure had lower amounts of unchanged diltiazem and of its main metabolite (MA)
## Abstract The present study investigates the urinary excretion of the enantiomers of (+)β and (β)βalbendazole sulfoxide (ASOX) and albendazole sulfone (ASON) in 12 patients with neurocysticercosis treated with albendazole for 8 days (7.5 mg/kg/12 h). Serial blood samples (0β12 h) and urine (three